Operating

Other Noncash Income (Expense)

Bristol-Myers Squibb Other Noncash Income (Expense) increased by 93.2% to -$21.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 320.0%, from -$5.00M to -$21.00M.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.

Detailed definition

This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...

Peer comparison

Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.

Metric ID: operating_other_noncash_income_expense

Historical Data

14 periods
 Q2 '21Q1 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$2.00M-$256.00M-$44.00M-$4.00M$13.00M-$269.00M-$40.00M-$23.00M-$103.00M-$5.00M$7.00M$74.00M-$308.00M-$21.00M
QoQ Change<-999%+82.8%+90.9%+425.0%<-999%+85.1%+42.5%-347.8%+95.1%+240.0%+957.1%-516.2%+93.2%
YoY Change+98.4%+9.1%-475.0%+61.7%+78.3%+171.8%-320.0%
Range-$308.00M$74.00M
CAGR+106.2%
Avg YoY Growth-53.7%
Median YoY Growth+61.7%

Frequently Asked Questions

What is Bristol-Myers Squibb's other noncash income (expense)?
Bristol-Myers Squibb (BMY) reported other noncash income (expense) of -$21.00M in Q1 2026.
How has Bristol-Myers Squibb's other noncash income (expense) changed year-over-year?
Bristol-Myers Squibb's other noncash income (expense) decreased by 320.0% year-over-year, from -$5.00M to -$21.00M.
What does other noncash income (expense) mean?
Miscellaneous non-cash income or expenses that impact net income but not cash flow.